High-Intensity Interval Training and Strength Conditioning in patients with Chronic Lymphocytic Leukemia: a systematic review.

Author:

Cunha Pedro1ORCID,Ribeiro Ricardo1,Pizarro Andreia1,Mota Jorge1,Ribeiro José1

Affiliation:

1. University of Porto Faculty of Sport: Universidade do Porto Faculdade de Desporto

Abstract

Abstract

Background This systematic review explores the impact of physical exercise (EX) on Chronic Lymphocytic Leukemia (CLL) patients' physical fitness, immunologic, and quality of life outcomes. Methods Eligible cohort studies were searched in PubMed and Web of Science up to February 2024 and were included if they involved participants in adult age, with confirmed CLL diagnose, using physical activity protocols with study design helding intervention protocols, clinical trials, or quantitative data reporting. Results This review identifies 92 studies, with 6 meeting the inclusion criteria. These studies focus on cardiovascular training combined with resistance training, continuous cardiovascular training, and endurance resistance training, highlighting the importance of EX in CLL patients before treatment, with significant improvements in physical fitness and immunologic parameters. However, none address strength training, which is known as one of the best options to increase muscular mass in physical activity (PA) interventions. Conclusions There is a gap in the literature regarding exercise influence on CLL, with small samples of patients in Pilot Study experiments. It is noted that exercise plays a vital role in improving physical fitness and immunologic parameters. But to advise Exercise Professionals on prescribing different modes of exercise, improving compliance with the prescribed exercise program, and determining which intervention in the context of exercise prescription should be used to maximize the benefits resulting from regular practice of EX, more studies are needed to evaluate the impact of PA on the health-related quality of life and life span of the CLL patient. Systematic review registration: This review was registered in PROSPERO International prospective register of systematic reviews with ID: CRD42023464877.

Publisher

Research Square Platform LLC

Reference54 articles.

1. Swerdlow SH, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2017.

2. Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study;Ou Y;Front Oncol,2022

3. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms;Alaggio R;Leukemia,2022

4. NIH. SEER Cancer Stat Facts: Chronic Lymphocytic Leukemia. 2022 2023/01/12 [cited 2023 2023/01/12]; https://seer.cancer.gov/statfacts/html/clyl.html.

5. The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019;Yao Y;Biomed Eng Online,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3